RASSF2 and neoplasm: Likewise, by classifying tumour samples from patients in this study on their inflammatory component (no inflammation, moderate inflammation, significant inflammation, presence of a Crohn-like inflammatory response), we report that this variable was statistically independent of RASSF2 gene promoter hypermethylation status.